H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 13.1% of adults in Topeka have diagnosed diabetes — 1.1 points above the U.S. 12% figure. Census population 126,587. Kansas Medicare wound biologics: WPS Government Health Administrators (J5). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Topeka clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Topeka storefront.
Growth Factor Therapy for Tissue Repair in Topeka, KS for clinics & physicians. Growth factor therapy prod… Compliance support & pricing — contact Hawk Medical.
Adult obesity in Topeka is 39.7% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. CDC PLACES (2023, crude) estimates 13.1% of adults in Topeka have diagnosed diabetes — 1.1 points above the U.S. 12% figure. Kansas is outside CDC’s core Diabetes Belt list; use the PLACES city rate anyway. Hawk Medical is the distributor for growth factor therapy, not a walk-in clinic.
National Growth Factor Therapy for Tissue Repair notes (how the product actually works)J5 reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Topeka is 13.1% or not. PLACES is planning data. The LCD is the claim.
If you already buy growth factor therapy elsewhere, use this page as a check: homologous-use language, current WPS Government Health Administrators article IDs, and PLACES 13.1% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 13.1% of adults — 1.1 points above the U.S. 12% figure. Obesity is 39.7%; arthritis is 27.5%. That is place-level BRFSS modeling, not a clinic census and not a Topeka trial.
Kansas is in CMS MAC J5, administered by WPS Government Health Administrators. CTP and skin-substitute coverage is written at the MAC level. Confirm the current LCD/article before you set utilization — we help practices map product to those rules; we do not override them.
Kansas is J5. A sister clinic in another state may be a different contractor with different CTP articles. Do not assume one utilization policy ports. We map both if you operate across MACs.
Regulatory lane, storage, and J5 coding. Amniotic products used as 361 HCT/Ps are not “better gauze.” Match wound stage and coverage article before you convert the cart.
If you operate in Kansas and another MAC state, say it on the first call. J5 will not port 1:1. We would rather split utilization than watch a sister clinic copy Topeka tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Topeka, KS.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Topeka is J5 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Topeka — 1.1 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Kansas Part B wound biologics follow this contractor (siblings: IA, MO, NE). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Topeka. Useful for joint-program math; still needs a diagnosis and privileging.
No Topeka storefront. Joe Bradley is an active practice owner. growth factor therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.